Epigallocatechin-3-gallate (EGCG), A Green Tea Polyphenol, Suppresses Hepatic Gluconeogenesis through 5′-AMP-activated Protein Kinase

Abstract

Epigallocatechin-3-gallate (EGCG), a main catechin of green tea, has been suggested to inhibit hepatic gluconeogenesis. However, the exact role and related mechanism have not been established. In this study, we examined the role of EGCG in hepatic gluconeogenesis at concentrations that are reachable by ingestion of pure EGCG or green tea, and are not toxic to hepatocytes. Our results show in isolated hepatocytes that EGCG at relatively low concentrations (<1 M) inhibited glucose production via gluconeogenesis and expression of key gluconeogenic genes. EGCG was not toxic at these concentrations while demonstrating significant cytotoxicity at 10 M and higher concentrations. EGCG at 1 M or lower concentrations effective in suppressing hepatic gluconeogenesis did not activate the insulin signaling pathway, but activated 5-AMP-activated protein kinase (AMPK). The EGCG suppression of hepatic gluconeogenesis was prevented by blockade of AMPK activity. In defining the mechanism by which EGCG activates AMPK, we found that the EGCG activation of AMPK was mediated by the Ca 2؉ /calmodulin-dependent protein kinase kinase (CaMKK). Furthermore, our results show that the EGCG activation of AMPK and EGCG suppression of hepatic gluconeogenesis were both dependent on production of reactive oxygen species (ROS), which was a known activator of CaMKK. Together, our results demonstrate an inhibitory role for EGCG in hepatic gluconeogenesis and shed new light on the mechanism by which EGCG suppresses gluconeogenesis.

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

“…Various natural molecules found in the human diet have been described as potential 4 agents to treat diabetes and hyperlipidemia [11][12][13][14]. Furthermore, recent studies have shown that some of these compounds strongly stimulate hepatic AMPK [11][12][13], an action that may help to explain some of the antihyperlipidemic effects of these natural derivatives and that provides an avenue for ameliorating hyperlipidemia and accelerated atherosclerosis in diabetes [11].…”

Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice

“…Natural products have played a significant role in new drug discovery and development processes [16], with some reported to possess glucose-lowering effects [17,18]. Moreover, natural products such as alkaloids, bitter melon extracts and epigallocatechin-3-gallate (EGCG) have been found to activate AMPK and improve metabolic disease [17,19]. However, most of these agents displayed inadequate efficacy in vivo, leading to the demand to develop more effective AMPK activators.…”

Novel pharmacological approaches to combat obesity and insulin resistance: targeting skeletal muscle with ‘exercise mimetics’

“…However, they did not report whether green tea extract alone enhanced endurance. Green tea catechins can activate AMPK in non-muscle cells [90,91], suggesting a mechanism similar to other AMPK activators such as AICAR [55] and resveratrol [50]. However, Murase et al [89] suggest that the actions of green tea extract in skeletal muscle are independent of PPARα/δ signalling, which contrasts with the purported mechanism of AICAR treatment [55].…”